Catalyst Wire Dossier Catalyst Wire Dossier

DEC-C

decitabine/cedazuridine
Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for DEC-C, covering 2025-03-24 to 2026-03-23. Get the full timeline:

Most recent: Clinical Trial Update: Pre-emptive Therapy With DEC-C to Improve Outcomes in MDS Patients With Measurable Residual Disease Post Allogeneic Hematopoietic Cell Transplant [Phase 1, Phase 2]

See pricing